Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Recruiting 2Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Sarcoma 1

Conditions

Sarcoma 3Pancreatic Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Leukemia, Myeloid, Acute 2Carcinoma, Hepatocellular 2Advanced Solid Tumors 2Advanced Endometrial Cancer 2Thrombosis 1Thrombophilia 1Solid Tumors 1Small Cell Lung Carcinoma 1Resectable Esophageal Squamous Cell Carcinoma 1Recurrence 1Rectal Neoplasms 1Ovarian Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Metastatic Solid Tumors 1Melanoma 1

Interventions

Cisplatin 9Radiotherapy 6Carboplatin 6toripalimab 5pembrolizumab 5Surgical Procedures, Operative 5Nivolumab 5Docetaxel 5Cetuximab 5Paclitaxel 4Drug Therapy 4Taxes 3Specimen Handling 3Magnetic Resonance Spectroscopy 3trilaciclib 2tislelizumab 2nimotuzumab 2camrelizumab 2Radiotherapy, Intensity-Modulated 2Injections 2Cyclophosphamide 2Blood Specimen Collection 2spartalizumab 1penpulimab 1fludarabine phosphate 1fludarabine 1dexamethasone-(C21-phosphoramide)-(anti-EGFR) 1dalpiciclib 1anlotinib 1Tea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Squamous Cell Carcinoma of Head and Neck × Injections × Clear all
NCT07586124 2026-05-14

Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

Lepu Biopharma Co., Ltd.

Phase 2 Not yet recruiting
80 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07491783 2026-03-24

Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

Sichuan Enray Pharmaceutical Sciences Company

Phase 2 Not yet recruiting
52 enrolled
Head & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡